The Position

• Leads signal detection, safety evaluation and risk management planning and activities for low‑medium complex, medicinal products and/or medical devices during clinical development and/or for established brands from a scientific perspective by active participation and contribution to, amongst others, the Organon Asset teams (when available), Risk Management Safety Teams (RMSTs), Safety Review Committee (SRC), LEAD/LAST and other safety related decision‑making governance bodies. Safeguard patient from harm.
• Lead Pharmacovigilance and Risk Management Planning and develops strategy for approach to evaluation of issues in the clinical matrix.
• Lead the safety contributions to integral regulatory submissions.
• Ensure that appropriate safety objectives and risk minimization strategies are included in clinical development programs and shows confidence, credibility and influence at all levels of the organization.
• Expert evaluati...